XBiotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2015
Market Capitalization	182	122	107	338	458	767	Upgrade
Market Cap Growth	135.74%	13.95%	-68.42%	-26.11%	-40.29%	321.45%	Upgrade
Enterprise Value	-9	-78	-111	101	221	52	Upgrade
PE Ratio	-	-4.96	-3.25	-19.43	-40.81	1.15	Upgrade
PS Ratio	-	-	26.64	18.39	10.41	-	Upgrade
PB Ratio	0.87	0.56	0.44	1.26	1.31	1.01	Upgrade
P/FCF Ratio	-11.39	-6.38	-6.93	5.13	-6.65	-41.51	Upgrade
P/OCF Ratio	-11.72	-6.50	-7.21	4.87	-7.03	-41.97	Upgrade
EV/Sales Ratio	-	-	-27.59	5.51	5.01	-	Upgrade
EV/EBITDA Ratio	-1.97	3.47	3.57	-4.44	-20.83	0.07	Upgrade
EV/EBIT Ratio	-1.86	3.22	3.29	-3.98	-17.20	0.07	Upgrade
EV/FCF Ratio	-2.60	4.10	7.18	1.54	-3.20	-2.83	Upgrade
Debt / Equity Ratio	0.05	-	-	-	-	-	Upgrade
Debt / EBITDA Ratio	-0.35	-	-	-	-	-	Upgrade
Debt / FCF Ratio	-0.46	-	-	-	-	-	Upgrade
Quick Ratio	11.91	32.79	53.49	68.63	79.45	13.12	Upgrade
Current Ratio	12.03	33.07	54.07	71.49	81.80	11.90	Upgrade
Asset Turnover	0	0	0.02	0.06	0.12	0	Upgrade
Return on Equity (ROE)	-14.00%	-10.80%	-13.10%	-5.60%	-3.20%	288.60%	Upgrade
Return on Assets (ROA)	-13.40%	-10.50%	-12.70%	-5.50%	-3.20%	268.70%	Upgrade
Return on Capital (ROIC)	-18.80%	-17.14%	-14.35%	-9.31%	-5.24%	-3.85%	Upgrade
Earnings Yield	-16.91%	-20.17%	-30.79%	-5.15%	-2.45%	87.19%	Upgrade
FCF Yield	-11.95%	-15.68%	-14.42%	19.48%	-15.04%	-2.41%	Upgrade
Dividend Yield	0.00%	0.00%	0.00%	22.50%	0.00%	0.00%	Upgrade
Payout Ratio	0.00%	0.00%	0.00%	-431.00%	0.00%	0.00%	Upgrade
Buyback Yield / Dilution	-0.02%	0.00%	-1.32%	2.53%	33.45%	-29.37%	Upgrade
Total Shareholder Return	-0.02%	0.00%	-1.32%	25.03%	33.45%	-29.37%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).